NAFDAC approves AstraZeneca COVID-19 vaccine

News - by RadioNow / Feb. 19th, 2021
covid vaccine astra zeneca Image sourced From University of Oxford

The National Agency for Food and Drug Administration and Control has approved the AstraZeneca COVID-19 vaccine for use in Nigeria.

The drug agency stated that the safety committee went to work immediately it received the vaccine dossiers last week to evaluate the vaccine safety and efficacy for Nigerians.

NAFDAC’s endorsement of the Oxford/AstraZeneca vaccine came after a team of scientists at the University of Edinburgh said B1525 variant of the virus whose earliest sequences were dated to December and cropped up in the UK and Nigeria could be vaccine-resistant.

The Nigerian government is looking to vaccinate a large percentage of its about 200 million population this year.

The African biggest economy has missed out on the first phase of the Pfizer COVID-19 vaccine, as WHO claimed the country doesn’t have adequate facilities to store the vaccine.

The 100,000 doses of the Pfizer vaccine initially expected in the country were replaced with 16 million doses of Astrazeneca vaccine.

As of Wednesday, Nigeria had recorded 148,500 cases of the viral infection including 1779 deaths.

Leave a Reply

Other Post

Social Share Buttons and Icons powered by Ultimatelysocial